Cleared Traditional

K152803 - SUNGSHIM STERILE SINGLE USE INSULIN SYRINGE

K152803 is an FDA 510(k) clearance for SUNGSHIM STERILE SINGLE USE INSULIN SYRINGE, manufactured by Sung Shim Medicare Co., Ltd.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 288-day FDA review.

K152803 · Sung Shim Medicare Co., Ltd. · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2016
Decision
288d
Days
Class 2
Risk

K152803 is an FDA 510(k) clearance for the SUNGSHIM STERILE SINGLE USE INSULIN SYRINGE. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Sung Shim Medicare Co., Ltd. (Sejing-Si, KR). The FDA issued a Cleared decision on July 12, 2016 after a review of 288 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K152803

510(k) Number K152803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2015
Decision Date July 12, 2016
Days to Decision 288 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
159d slower than avg
Panel avg: 129d · This submission: 288d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Plusglobal
PETER CHUNG

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FMF Syringe, Piston

All 586
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K152803.
Bone Solutions Mixing and Delivery System
K161568 · Bone Solutions, Inc. · Sep 2016
Sure-Fine Insulin Syringes
K152879 · Shina Med Corporation · Sep 2016
InPen
K160629 · Companion Medical, Inc. · Jul 2016
BD U-500 INSULIN SYRINGE
K151870 · Becton, Dickinson and Company · Jul 2016
LITe BIO Delivery System
K160978 · Stryker Corporation · Jul 2016
Sol-M Insulin Syringe, Sol-M TB Syringe
K153537 · Sol-Millennium Medical, Inc. · Jun 2016